Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q1 2022 · 10-Q
Revenue$15.08K$15.08Kno prior Q1 2021 on file Net Income-$4.59M-$4.59MN/M vs Q1 2021 EPS, diluted—
Operating Income-$4,610,127N/M Operating Cash Flow-$5,636,952N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
Free Cash Flowderived-$5,723,999— Margins · derivedOperating margin-30565.1%
Net margin-30438.2%
ended Mar 31, 2022 · filed May 13, 2022 · 43 d after period end